Amundi’s IDEAYA Biosciences IDYA Stock Holding History

Amundi’s Portfolio IDYA Stock Details IDYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-73	Closed	-$1.14K	–	1902
2025 Q1	$1.14K	Buy	73 +40	+121%	+$852	﹤0.01%	2018
2024 Q4	$820	Buy	+33	New	+$934	﹤0.01%	2048

Other funds holding IDYA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Amundi's IDYA Position: Q2 2025 in Review

Amundi sold out of IDEAYA Biosciences (IDYA) in Q2 2025, closing a stake of 73 shares — an estimated $1.14K sold.

Amundi first reported a position in IDYA in Q4 2024 and held it in 2 quarters. The position peaked at $1.14K in Q1 2025. 204 funds tracked by Wall St. Rank hold IDYA as of Q2 2025.

Amundi reported no remaining IDEAYA Biosciences position as of Q2 2025 after selling out during the quarter.
Amundi sold 73 IDEAYA Biosciences shares in Q2 2025, an estimated $1.14K.
Amundi first reported a position in IDEAYA Biosciences in Q4 2024 and held it in 2 quarters.
Amundi's IDEAYA Biosciences position peaked at $1.14K in Q1 2025.
204 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2025.

Based on Amundi's 13F filing for Q2 2025, filed 13 Aug 2025.